A recent development in treating pancreatic cancer offers new hope. After extensive research, an innovative experimental drug has emerged, taken once a day. This drug is showing effectiveness in prolonging the lives of patients.
By focusing on slowing the progression of pancreatic cancer, which is known for its low survival rates, this drug could change the outlook for many individuals diagnosed with the disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, contributes insights to the ongoing efforts in combating this cancer.
In an interview with Stephanie Sy, PBS News Hour correspondent, Dr. Shroff discusses the implications of this breakthrough. Stephanie Sy, a seasoned journalist, has extensive experience with PBS News Hour, Al Jazeera America, CNN International, and other major news outlets. Her reporting has covered significant events, including the 2018 Midterm Elections and providing live reports from key political moments.

The Future of MAHA in American Health Politics
Insulin Cost Caps Gaining Support Amid Rising Prices
Efforts to Counter Food Assistance Cutbacks in San Diego
A Personal Journey Through Encephalitis
Low-Cost Medication May Benefit Stroke Survivors
The Complex Debate Over Kratom Use in the U.S.